Alzheimer’s Association International Conference® 2026 (AAIC®)
12-15 July 2026 | London
Jane Rhodes, Chief Executive Officer attending event
Jane Rhodes, Chief Executive Officer attending event
Jane Rhodes, Chief Executive Officer
Presentation: Wednesday 24 June, 14:00-14:15 PDT, Theater 4
Michelle Mellion, Chief Medical Officer and Deb Gouveia, VP, Clinical Operations and Development Strategy attending event
Magnus Ivarsson, Chief Scientific Officer
“Modulating Sleep As An Entry Point To Treating Neurodegenerative Disorders” presentation
Tuesday 16 June 2026, 09:25-09:50 CEST